Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ERAS[® ]INTERACTIVE AUDIT SYSTEM FOR QUALITY IMPROVEMENT IN THE CLINICAL HEALTHCARE SETTING

A newly published article “Enhanced Recovery After Surgery Interactive Audit System: 10 years’ Experience with an international Web-Based Clinical and Research Perioperative Care Database” shows that the ERAS[®] Interactive Audit System (EIAS) supports the collaborative clinical effort in driving quality improvement in the perioperative care in a short time frame, in an international context. The safety of the established ERAS[®] Protocols has demonstrated in numerous studies the efficacy of ERAS[®]. Reduction in morbidity, faster return of bowel function, earlier mobilization,

Sandvik receives several high value-added tubular orders

Sandvik Materials Technology has received several orders for advanced tubes for the oil and gas industry at a combined value of about 1 billion SEK, with the majority being umbilical tubes. Orders were booked in the first quarter of 2019 and deliveries are scheduled as from the second half of 2019. “I am pleased that our strong product offering continue to meet customer demands, making us a key supplier of high value-added tubular products for the energy segment”, says Göran Björkman, President of Sandvik Materials Technology.   Stockholm, 21 January 2019 Sandvik AB For further

Eagle Filters receives 0,8 MEUR funding from Loudspring and enters into strategic alliance with Australian Baltec IES

Loudspring has extended an 800 000 EUR loan to its daughter company Eagle Filters. Loudspring recently agreed on 2,5M EUR growth financing from the Nordic Environmental Finance Corporation (NEFCO). The loan to Eagle Filters is the first deployment of the NEFCO funding for Loudspring, and provides Eagle Filters with the resources to accelerate its growth strategy. Loudspring owns 67,6% of Eagle Filters and has an option to increase its ownership to 80%. Eagle Filters and Australian Baltec IES  are commencing combined marketing and technology efforts to

Share buy-backs in Telia Company during week 3 2019

During the period January 14, 2019, until January 18, 2019, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2,585,000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 20, 2018. The share buy-back programme, which runs between April 23, 2018, and March 22, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

Powerbox announces power supply industry’s first Cosel portable product selector app

Powerbox , one of Europe’s largest power supply companies and a leading force for four decades in optimizing power solutions for demanding applications, has announced the release of Cosel’s first portable product selector app developed to operate across all mobile devices and computers - even without internet connection. The application has been designed for speed, and coded to offer power designers and sales forces quick access to the most important parameters, helping them to choose the best Cosel power solution for their applications in just a few clicks.

Indoor air expert: Attention must be paid to the amount of chemicals in new buildings

The impact of building materials on indoor air should be examined more.The emission class M1 for building materials is often seen as a guarantee of good indoor air. The aim of the M1 classification is to promote the development and use of low-emission products in construction. According to Juhani Pirinen, head of a business unit at FCG, the use of the classification has reduced the chemical levels in new buildings drastically. "The M1 classification ensures that the products produce fewer emissions. The classification cannot, however, enable fully emission-free construction and

Kurt Jofs to replace Staffan Bohman as Chairman of Höganäs Board of Directors

Kurt Jofs assumes the position as Chairman of the Höganäs Board on February 6, 2019. He succeeds Staffan Bohman, who has held the Chairman position for the company since 2013 when Lindéngruppen and FAM bought and delisted Höganäs from the stock exchange.“I look forward to taking over the role of Chairman and continuing Staffan Bohman’s fine work”, says Kurt Jofs. “Höganäs is an interesting company with a long and proud history, and today it has great potential in several different markets.” Kurt Jofs has been a member of the Höganäs Board of Directors since 2013. He brings with him a

BerGenBio announces start of phase I trial evaluating ADCT-601, a novel anti-AXL ADC, in patients with advanced solid tumours

· ADCT-601 uses a proprietary AXL antibody developed by BerGenBio and licensed to ADC Therapeutics for antibody drug conjugate (ADC) development · Phase I dose escalation and expansion trial will evaluate ADCT-601 in 75 cancer patients · ADCT-601 is BerGenBio’s third clinical candidate targeting AXLBergen, Norway, January 21 2019 - BerGenBio ASA (OSE:BGBIO), announces that the first patient has been dosed in a phase I clinical trial evaluating the safety, tolerability, pharmacokinetics and anti-tumour efficacy of ADCT-601, an AXL-targeting antibody drug conjugate (ADC), in patients

Targovax is invited to present at upcoming investor conferences

Oslo, Norway, 21 January 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that members of its senior management team will present at upcoming investor conferences.Date: 22 January 2019Venue: Redeye Fight Cancer Seminar, Stockholm, SwedenPresenter: Erik Digman Wiklund (CBO)Presentation:-    Time: 10:45 CETPanel discussion:-    The field of Immuno-oncology - how to optimize clinical development - what trends do you see in the market?-    Time: 11:40 CETThe event can be followed

Press release English

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed tempus sem dapibus diam pharetra, eget eleifend enim tristique. Suspendisse potenti. Ut vitae velit eu nibh adipiscing dapibus ac eget eros. Sed faucibus gravida urna non bibendum. Donec mattis egestas ullamcorper.Donec blandit massa felis, ut laoreet mi tempus vehicula. Fusce feugiat ac mauris ac pellentesque. · Fusce vitae libero nec ligula egestas posuere. Curabitur nec commodo urna. Sed varius interdum lacus at adipiscing. · Nam sodales, turpis quis gravida ultrices, quam purus consequat leo, vel sodales nisl massa

Warm welcome for ABB Formula E in Davos

Zurich, Switzerland, January 19, 2019 Just a few days before the start of the World Economic Forum 2019, Davos is celebrating a world premiere: The latest ABB FIA Formula E racing car - dubbed Gen2 – was transported on a train from the iconic Swiss Rhaetian Railway to Europe’s highest city, where it will be an exciting eyecatcher during the coming week at the Davos Platz railway station. From this Saturday until next Sunday, January 27, the Gen2 will be on display in a special glass case. Interested passersby can learn about the ABB FIA Formula E racing series as well as about

Write-down of goodwill in Cabonline´s Year-end report 2018

The yearly impairment test in Cabonline has resulted in a non cash charge of goodwill  amounting to approximately 155 MSEK referring to the business in Finland. The Goodwill originates from the acquisition of Kovanen, Maankan Taksi and Inva-Taksi, Finland 2017.The write-down has no cash flow effect, however it has a negative impact on reported Operating income for 2018 in segment Finland. The long-term strategy regarding the presence and growth in Finland following the deregulation of the market in July 2018 remains. The amount is unaudited and the final number will be published in the Year-

WOW air hf. – All Warrant holders agree to Warrant Cancellation Agreement

ISIN: NO0010832785 – Senior Floating Rate Bonds with an aggregate outstanding amount of USD 60,000,000. Reference is made to the market announcement of WOW air (“WOW“), dated 29 November 2018, of the signing of a term sheet for the proposed investment of Indigo Partners LLC ("Indigo Partners") in WOW air. In connection with the aforementioned bonds, WOW issued on 2 November 2018 share warrant instruments (the "Warrants"). Pursuant to a Share Purchase Agreement that will be negotiated between the Indigo Investor and the shareholders of WOW, the shareholders of WOW undertook to

Decision on Extraordinary General Meeting in QuickCool AB (publ)

At a board meeting on 17 January the Board of Directors of QuickCool AB (publ) ("Quickcool" or "Company") decided to call for an extraordinary general meeting on 18 February 2019 at 17.00. (Notice will be issued in a separate press release).The Board of Directors proposes that the EGM:  Decides to change the articles of association so as to enable the aggregation of shares and decides on reducing the share capital. The board of Directors proposes that the limits of the articles of association for the share capital (§ 4) and the company's shares (§ 5) are amended in accordance with the

Decision to direct share issue to the European High Growth Opportunities Securitization Fund

The Board of Directors of QuickCool AB (publ) ("QuickCool"), supported by the authorization from the annual general meeting on May 3, 2018, decided a directed share issue, with exemption from the shareholders ' preferential rights. The new share issue has been addressed to the European High Growth opportunities Securitization Fund.The purpose of the directed share issue has been to fulfil one of the terms of the financing agreement that Quickcool entered with the European High Growth Opportunities Securitization Fund. Information about the financing agreement was provided through a press

Railcare builds generator wagons for Infranord

Railcare has received an order to build a new generation of generator wagons for the railway contracting company Infranord. The order value amounts to approximately MSEK 30 and consists of 5 wagons, designed together with Infranord. "We are excited about this collaboration with Infranord, they have the confidence in Railcare to build generator wagons that meet Infranord's high standards of adaptation for today's working environment," says Daniel Öholm, CEO Railcare Group AB. "The delivery of the wagons will begin in autumn 2019, with final delivery in 2020. The order will be reported in

Cereno Scientific recalls tranche of convertible bonds and pauses financing from EHGOSF

The Board of Directors of Cereno Scientific has decided to recall the latest tranche that the company issued on 4 January 2019, and to pause until further notice the call-down of new convertible bonds in the funding solution the company entered into with the European High Growth Opportunities Securitization Fund. The Board is evaluating various alternate funding solutions to finance continued operations and the planned Phase II study of its drug candidate, CS1.“We have agreed, in consultation with the European High Growth Opportunities Securitization Fund through their adviser, Alpha Blue

European High Growth Opportunities Securitization Fund requests conversion of convertible bonds

European High Growth Opportunities Securitization Fund has by notice to the board of directors of QuickCool AB (Publ) ("QuickCool") called upon its right to conversion of convertible bonds previously issued in accordance with the financing solution announced by QuickCool through a press release on 21 June 2018.QuickCool has received notification from European High Growth Opportunities Securitization Fund regarding conversion of convertible bonds into 833 333 shares in QuickCool, corresponding to SEK 499 999,80 of the convertible loan. The conversion price per share is SEK 0,60. Upon

Invitation – Year-End Report 2018 presentation

Husqvarna Group’s Year-End Report 2018 will be published 08:00 CET on February 5. The report and conference call slides will be available at www.husqvarnagroup.com/ir. Results presentation, conference call and audio cast at 10:00 CET Financial analysts and media are invited to a presentation of the results at 10:00 CET the same day, hosted by Kai Wärn, President and CEO and Glen Instone, CFO. The presentation will be held at Husqvarna Group’s office at Regeringsgatan 28 in Stockholm. Dial in details and audio web cast To participate by phone, dial +46 (0) 8 566 184 30 (Sweden)

Castellum sells entire portfolio in Sundsvall and acquires six properties in Linköping

Castellum has completed an exchange transaction with Fastighetsaktiebolaget Lilium, wherein Castellum will acquire six properties in Linköping, and sell twenty properties in Sundsvall. Vacancy/Occupancy dates occur March 1, 2019.“Linköping is an attractive regional city where we’d like to grow and develop our product offers. This transaction makes us one of the two largest players in town, and moreover, the deal provides building-rights possibilities in the city. With us as a partner, both existing and new customers can grow and develop their businesses as well”, says Henrik Saxborn,

Induct - Primary Insider Information

NPP Capital AS lawsuit against European High Growth Opportunities Securitization FundReference is made to announcement by Induct on 13 December 2018 regarding NPP Capital AS ("NPP"), a company owned 100% by Alf Martin Johansen, CEO of Induct, lending of 306,748 shares in Induct to European High Growth Opportunities Securitization Fund ("European"). These shares were considered lost by NPP due to European not accepting redelivery of the shares according to share lending agreement.   NPP thereafter purchased 306,748 shares in the market to regain the lent shares, see announcement by Induct

Nightingale Health to receive EUR 20 million EU-financing to herald a new era of chronic disease prevention

· EUR 20 million EIB loan will be used to accelerate research and development of Nightingale’s blood analysis technology. · Loan backed by European Fund for Strategic Investments, part of the Juncker Plan.Nightingale Health, the Finnish innovator of an internationally recognized blood analysis technology for chronic disease prevention, today signed a EUR 20 million loan transaction with the European Investment Bank (EIB), guaranteed by the European Fund for Strategic Investments (EFSI) , a key element of the Investment Plan for Europe 

There are no items matching the current filter
There are no more items matching the current filter
Back to top